Growth via IPO IVC Evidensia is planning an IPO in 2026, signaling a potential surge in demand for scalable technology, premium services, and enterprise-grade operations efficiency. This creates opportunities to offer patient management, analytics, compliance, and international expansion support to streamline pre- and post-IPO readiness.

Expansion Playbook With recent and ongoing regional executive hires across Northern Europe and Central Europe, there is a clear push for geographic growth. Sales opportunities exist in centralized veterinary platforms, cross-border integration, unified ERP/CRM systems, and standardized training programs for multi-country operations.

Tech Modernization Board-level CIO exits and a large global workforce indicate a window for modernizing IT infrastructure, cybersecurity, data analytics, and enterprise collaboration. Target offerings include cloud-based VET practice management, data dashboards, and digital onboarding solutions.

Talent & Engagement Recognition as a Top Employer and ongoing leadership appointments point to an emphasis on workforce capability and retention. Potential opportunities exist in HR tech, learning platforms, e-signature workflows, and employee experience tools tailored for multi-country veterinary groups.

Quality & Scale Significant funding and a vision to be the world's best veterinary group imply a demand for scalable, compliant operations across multiple markets. Ideal fit areas include centralized credentialing, quality assurance, clinical guidelines governance, and standardized supplier/vendor management.